Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Secondary analysis from the Phase 3 MAESTRO-NASH and MAESTRO-NAFLD-1 trials examines improvements in lipid profiles for Lp(a), LDL-C and ApoB ...

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH

Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...
clinicaladvisor.com

Rezdiffra for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis

In March 2024, the US Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra™ (resmetirom) in conjunction with diet and exercise for the treatment of adults with noncirrhotic ...
Grice Connect

Karl Peace, Ph.D., honored by VCU School of Public Health for contributions to the field

A run through the MCV Campus helped put Karl Peace, Ph.D., on track toward a storied biostatistics career, shaping access to ...
verywellhealth

Is It Safe to Cut Cholesterol-Lowering Drugs in Half?

Some cholesterol medications like Lipitor and Crestor are safe to split. Extended-release pills or capsules cannot be split because it can be dangerous. Cutting cholesterol-lowering drugs in half can ...
WebMD

Cholesterol Medications

Colesevelam (Welchol) Colestipol (Colestid) Evolocumab (Repatha) E zetimibe ( Zetia ) Fenofibrate (Fenoglide, Lipofen, Lofibra) Fenofibrate nanocrystallized (Tricor, Triglide) Fenofibrate, micronize d ...